TNNT2 and hydrops fetalis: For example, a change in hs-cTnT that was more than 50% from baseline was associated with an even higher risk of developing HF (adjusted HR = 1.61; 95% CI 1.32–1.97) and higher cardiovascular mortality (adjusted HR 1.65; 95% CI 1.35–2.03).